Stemcell United Limited Stock Australian S.E.
Equities
BP8
AU000000SCU9
Biotechnology & Medical Research
Sales 2022 | 14.35M 9.51M 13.07M | Sales 2023 | 339 224.68 308.61 | Capitalization | 3.85M 2.55M 3.51M |
---|---|---|---|---|---|
Net income 2022 | -3M -1.99M -2.73M | Net income 2023 | -4M -2.65M -3.64M | EV / Sales 2022 | 1.07 x |
Net Debt 2022 | 627K 415K 571K | Net cash position 2023 | 511K 339K 465K | EV / Sales 2023 | 9,862 x |
P/E ratio 2022 |
-3.97
x | P/E ratio 2023 |
-0.72
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 35.23% |
Managers | Title | Age | Since |
---|---|---|---|
Matthew Leonard
CEO | Chief Executive Officer | 53 | 23-03-29 |
Justyn Stedwell
SEC | Corporate Secretary | - | 04-10 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | 21-07-20 | |
Paul Stephenson
CHM | Chairman | 63 | 20-03-30 |
Yan Hua Huang
BRD | Director/Board Member | - | 19-05-26 |
1st Jan change | Capi. | |
---|---|---|
+38.66% | 52.85B | |
-7.81% | 38.87B | |
+35.31% | 38.24B | |
-10.77% | 26.79B | |
+11.77% | 26.16B | |
-17.82% | 19.9B | |
+35.09% | 13.18B | |
+29.17% | 12.24B | |
-3.05% | 11.79B |